Whatman launched this week its Protran nitrocellulose membranes for blotting biomolecules such as nucleic acids and proteins. According to Whatman, Protran has the highest mechanical stability and tensile strength of all available nitrocellulose membranes. In addition, Protran's nitrocellulose formula allows proteins to maintain molecular recognition activity for five years, the company said.
Nimes, France-based Proteus announced this week the launch of a new business unit called Proteus Services for Industry, or PSI, that is dedicated to providing protein engineering and production services for the life sciences industries.
"With PSI, our customers can now benefit from our expertise and technologies for producing and engineering their own proteins," said Daniel Dupret, president and CEO of Proteus.
Movers & Shakers
Sigma-Aldrich announced several internal management changes this week in connection with its recent reorganization.
Shaf Yousaf, vice president of corporate R&D and biotechnology marketing, will become president of the firm's new Biotech unit.
David Julien, most recently president of Sigma's biotechnology business, was named president of the new Specialties unit.
Gilles Cottier, vice president of sales at Sigma, was appointed president of the new Essentials unit.
The firm's SAFC business unit will continue to be led by Frank Wicks, who has served as its president since January 2003.
Douglas Liu has joined Qiagen as vice president of global operations, the company said this week. He will also serve on the firm's executive committee and will be based at Qiagen's headquarters in Hilden, Germany. Liu comes to Qiagen from Bayer Healthcare, where he was head of operations for nucleic acid diagnostics in the US and worked in strategic planning and consulting at Bayer's headquarters in Germany. Liu holds an MBA from Boston University and a BS from the University of Illinois.
Steve Noblitt has been promoted to US sales manager of Nonlinear USA, the US subsidiary of Nonlinear Dynamics, the company said this week. For the past four years, he was Nonlinear's Midwest sales manager. Prior to that, he worked as a field applications specialist for Molecular Dynamics and Amersham Pharmacia Biotech.
John Wareham, who retired from his position as chairman and CEO of Beckman Coulter in February, entered into a retirement and consulting agreement with the company on June 30, according to an SEC filing last week. Wareham will serve as a consultant for three years.
John Mendlein has become the chief executive officer of Compound Therapeutics of Waltham, Mass., ProteoMonitor's sister publication, GenomeWeb News has learned. He is the former CEO of Integrative Proteomics.
Paul Blake has been elected to the board of directors of ViaCell, the Boston-based company said this week. Blake is executive vice president for worldwide clinical research and regulatory affairs at Cephalon. Prior to that, he was chief medical officer of MDS Proteomics. Blake holds a medical degree from London University.